-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Maintains Buy on Cellebrite DI, Lowers Price Target to $15

Benzinga·08/14/2026 20:08:25
Listen to the news
Lake Street analyst Eric Martinuzzi maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $21 to $15.